Document Detail


Respiratory syncytial virus infection in patients with cancer: still more questions than answers.
MedLine Citation:
PMID:  18540811     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Arne Simon; Oliver Schildgen; Marcus Panning; Udo Bode; Anna Maria Eis-Huebinger
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  46     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-06-10     Completed Date:  2008-07-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1933-4; author reply 1934-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antibodies, Monoclonal / therapeutic use
Antiviral Agents / therapeutic use
Child
Child, Preschool
Female
Hematologic Neoplasms / complications*,  immunology,  therapy*
Humans
Infant
Male
Neoplasms / complications*,  immunology,  therapy*
Respiratory Syncytial Virus Infections / epidemiology*,  immunology
Respiratory Syncytial Viruses / isolation & purification*
Ribavirin / therapeutic use
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antiviral Agents; 0/palivizumab; 36791-04-5/Ribavirin
Comments/Corrections
Comment On:
Clin Infect Dis. 2008 Feb 1;46(3):402-12   [PMID:  18181739 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir mono...
Next Document:  Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and H...